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Purpose: The membrane-type frizzled-related protein (MFRP) gene is selectively expressed in the retinal pigment
epithelium and ciliary body, and mutations of this gene cause nanophthalmos. The MFRP gene may not be essential for
retinal function but has been hypothesized to play a role in ocular axial length regulation. The involvement of the
MFRP gene in moderate to high hyperopic, isolated microphthalmic/anophthalmic, and high myopic patients was tested
in two phases: a mutation screening/sequence variant discovery phase and a genetic association study phase.
Methods: Eleven hyperopic, ten microphthalmic/anophthalmic, and seven non-syndromic high-grade myopic patients of
varying ages and 11 control subjects participated in the mutation screening phase. Sixteen primer pairs were designed to
amplify the 13 exons of the MFRP gene including intron/exon boundaries. Polymerase chain reactions were performed,
and amplified products were sequenced using standard techniques. Normal and affected individual DNA sequences were
compared alongside the known reference sequence (UCSC genome browser) for the MFRP gene. The genetic association
study included 146 multiplex non-syndromic high-grade myopia families. Seventeen intragenic and flanking single
nucleotide polymorphisms (SNPs) were chosen for the MFRP gene and genotyped in the large data set using the
Taqman® allelic discrimination assay. The family-based association Pedigree Disequilibrium Test (PDT) and GenoPDT
were performed.
Results: The average spherical refractive error of the hyperopic patient cohort was +4.21 diopters (D; range +2.00 to
+9.25 D) and of the myopic patient cohort was −12.36 D (range −8.25 to −14.50 D). A total of 16 SNPs were identified
by direct sequencing. No significant association was determined between the 16 MFRP gene SNPs and the moderate to
high hyperopia, microphthalmia/anophthalmia affection status, and high myopia. Family based association analysis did
not reveal any association between the 17 SNPs genotyped in the larger family data set for any refractive error type.
Conclusions: Sequence variants of the MFRP gene do not appear to be associated with either the less severe forms of
hyperopia, extreme forms of limited eye growth and development, or high myopia. These results indicate that the
MFRP gene may not play a role in regulating ocular axial length in these phenotypes.
The coordinated growth-related changes of various
components of the eye are required to achieve and maintain
emmetropia (the ideal refractive state). During this process of
regulated ocular growth, the axial length (distance along the
visual axis between cornea and retina) is a critical determinant
of refractive status [1,2]. Disruption in the regulation of ocular
growth results in the development of refractive error. It is now
widely accepted that both environmental and genetic
influences contribute to refractive error development.
Recently, four independent mutations were identified in the
membrane-type frizzled-related protein (MFRP) gene
associated with nanophthalmos, a rare disorder of eye
development characterized by extreme hyperopia (farsighted
refractive error) [3]. Mutations in the MFRP gene have also
Correspondence to: Terri L. Young, M.D., Professor of
Ophthalmology and Pediatrics, Duke University Center for Human
Genetics, 595 La Salle Street, Durham, NC, 27710; Phone: (919)
681-5675; FAX: (919) 684-0906; email:
tyoung@chg.duhs.duke.edu
been reported in a distinct autosomal recessive ophthalmic
syndrome characterized by microphthalmos, retinitis
pigmentosa, foveoschisis, and optic disc drusen [4].
MFRP is a gene that is selectively expressed in the retinal
pigment epithelium (RPE) and ciliary body [3] and encodes a
transmembrane receptor protein that contains a cysteine-rich
domain (CRD) [5]. CRDs are binding motifs for wingless-
type proteins (WNTs), a family of cell signaling molecules
that mediate cell growth, differentiation, and development,
and along with frizzled proteins, are implicated in eye
development and disease ([6] for a detailed review). While
Ayala-Ramirez et al. [4] stated that the MFRP gene is
necessary for photoreceptor maintenance due to the severe
rod-cone dystrophy of their patients, Sundin et al. [3]
maintained that MFRP is not critical for retinal function.
However, Sundin et al. [3] proposed a role for MFRP in the
regulation of ocular axial length.
High hyperopia, microphthalmia, anophthalmia, and high
myopia are all ocular disorders that present with altered ocular
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387axial length. While microphthalmia and anophthalmia with
very high hyperopia are rare and extreme phenotypes [7],
moderate to high hyperopia [8] and high myopia ([9] for a
detailed review) are relatively more prevalent. All of these
conditions with high degrees of refractive error potentially
result in secondary complications and visual loss. High
degrees of hyperopia are associated with a narrow angle
between the iris and cornea, an expansion of the choroidal
vascular bed, choroidal folds, and thickened sclera [10–12]
and can lead to angle closure glaucoma and retinal detachment
(RD). High myopia is frequently associated with cataract,
glaucoma, retinal detachment, and posterior staphyloma with
retinal degenerative changes including choroidal
neovascularization [13,14]. In addition to pathology leading
to visual loss, refractive error prevalence has a high public
health and economic impact [15], thus, it is important to
understand ocular growth regulation in refractive error
development.
We hypothesized that the MFRP gene is important in the
ocular axial length regulation of all types. In this study, we
screened for sequence variants in the MFRP gene and tested
for genetic association in moderate to high hyperopic, non-
syndromic microphthalmic or anophthalmic, and non-
syndromic high myopic patients. We sought to investigate
whether sequence variants of MFRP are associated with less
severe forms of hyperopia, other extreme forms of limited eye
growth and development or high myopia and whether the
MFRP gene plays a role in regulating ocular axial length in
general.
METHODS
Patient information: Informed consent was obtained from all
participants, and total genomic DNA was extracted from
venous blood using AutoPure LS® DNA Extractor and
PUREGENE™ reagents (Gentra Systems Inc., Minneapolis,
MN). The study was approved by the Institutional Review
Board at Duke University and followed the principles of the
Declaration of Helsinki. Eleven moderate to high hyperopic
subjects, 10 microphthalmic/anophthalmic patients, 11
control subjects, and seven high-grade myopic subjects of
varying ages participated in the sequencing study. A large data
set comprising of 146 multiplex families that included 634
subjects was used for the genotyping study. Those with
systemic conditions and syndromic disorders that could
predispose them to their refractive status were ruled out by an
ophthalmic physician and geneticist if necessary.
Primers: The MFRP gene maps to chromosome 11q23.3 and
spans the distance between genomic positions 118716837 and
118722580 (UCSC genome browser - Human Mar. 2006
[hg18] assembly). It is composed of 13 exons, and its genomic
structure is detailed in Figure 1. Sixteen primer pairs were
designed to amplify the identified 13 exons including the 5′
and 3′ untranslated regions (covering 50–150 base pairs [bp]
of each intron-exon boundary; Table 1).
Sequencing analyses: Polymerase chain reactions (PCRs)
were performed on genomic DNA using Platinum® Taq DNA
polymerase (Invitrogen Corporation, Carlsbad, CA) using a
touchdown protocol (available upon request). Amplicons
were visualized by means of agarose gel electrophoresis and
were purified with Quickstep™ 2 SOPE™ Resin (Edge
BioSystems, Gaithersburg, MD). Sequencing reactions were
performed using BigDye™ Terminator on ABI3730 or 3100
Genetic Analyzer (Applied Biosystems Inc., Foster City, CA).
Sequences were trimmed for quality and aligned using
Sequencher™ (Gene Codes, Ann Arbor, MI). Individual
DNA sequences were compared alongside the known
reference sequence for MFRP (UCSC genome browser,
Representative Refseq: NM_031433).
Genotyping: Seventeen single nucleotide polymorphisms
(SNPs) were chosen to cover the MFRP gene and its flanking
regions. We applied SNPSelector® [16] to select tagging SNPs
that met the following two criteria: (1) a Pearson correlation
(r2) of at least 0.67 in the linkage disequilibrium (LD) bins and
(2) a minor allele frequency of at least 5% in the Caucasian
population. The SNPs that were chosen were rs2509656,
rs11217240, rs11217241, rs669462, rs948413, rs948414,
rs10790289, rs12294677, rs12421909, rs883247, rs883245,
rs3814758, rs12577147, rs11217244, rs7932692,
rs10892353, and rs7122785. A custom TaqMan® allelic
discrimination assay, which consisted of a mix of unlabeled
PCR primers and the TaqMan® minor groove binding group
(MGB) probe (FAM™ and VIC® dye-labeled; Applied
Biosystems Inc.), was used. This assay comprised of two
unlabeled PCR primers and two allele-specific probes. PCR
reactions were performed with the Taqman® Universal PCR
Master Mix on GeneAmp® PCR System 9700 (Applied
Biosystems Inc.), and the ABI7900HT Fast PCR System
(Applied Biosystems Inc.) was used for reading the allelic
discrimination calls.
Statistical analyses: For sequencing data, all SNPs were tested
for association using the Fisher Exact Test with a significance
level threshold of 0.05. For genotyping data, family-based
Pedigree Disequilibrium Test (PDT) and Genotype Pedigree
Disequilibrium Test (GenoPDT) were used to test for the
association of markers in groups comprising of high myopes
(≤5.00 D) and moderate-high hyperopes (≥+2.00 D) in
comparison to control subjects (between +0.50 and −0.50 D).
Figure 1. Schematic representation of the genomic arrangement of
MFRP on chromosome 11q23.3. The vertical boxes represent exons,
the horizontal bars represent introns, and the arrow heads represent
the direction of transcription (source; UCSC genome browser).
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For the patient samples used for direct sequencing, the average
spherical refractive error of the hyperopic patient group was
+4.21 diopters (D; range +2.00 to +9.25 D) and of the myopic
patient group was −12.36 D (range −8.25 to −14.50 D). The
refractive  status  findings  for  the  hyperopic  and  myopic
patients are listed in Table 2.
A total of 16 SNPs were identified by direct sequencing.
A synonymous SNP (rs36015759) in exon 5 was observed in
six  hyperopic  (five  heterozygous,  one  substitution),  six
microphthalmic/anophthalmic,  two  high  myopic,  and  five
control subjects (all heterozygous). Five other known SNPs
(rs883245 and rs883247 in the 5′ UTR, rs3814762 in exon 4,
rs2510143 in exon 5, and rs948411 in intron 9) were observed
in the hyperopic, microphthalmic/anophthalmic, and high-
grade myopic patients as well as the control subjects (see
Table 3 for details). In addition, 10 isolated, novel SNPs were
identified in exons 5 (synonymous), 6 (non-synonymous), 8
(synonymous), 9 (non-synonymous), and 13 (3′ UTR) as well
as in introns 8 and 11. No significant association was obtained
for any SNP with any of the phenotypes studied. In addition,
the family-based association study using a larger set of family
data did not reveal any significant association of markers
genotyped with either the hyperopic or myopic groups when
compared to the control group. The results obtained from the
family-based association PDT and GenoPDT analyses are
listed in Table 4.
DISCUSSION
There  is  strong  evidence  for  a  heritable  effect  for  high
hyperopia [17,18], microphthalmia [19,20], and high myopia
[9]. The MFRP gene is predominantly expressed in the eye
and  at  low  levels  in  the  brain  [5,21],  and  its  selective
expression in the RPE makes it an ideal candidate gene for the
proposed role in axial length regulation. During ocular axial
length regulation, a retino-scleral signaling cascade has been
postulated to explain the changes in the scleral structure and
composition  [22].  The  RPE  layer  has  been  proposed  to
transmit these signals [23]. Furthermore, the potential for
MFRP interactions (via the cysteine-rich domain) with WNT
TABLE 1. MFRP GENE PRIMERS FOR SEQUENCE VARIANTS’ SCREENING.
Exon 5′-3′ Sequence Fragment size (bp) Chromosomal location
Exon1_F CAGCTGAGTTGGATTAAGGGAC 118722259
Exon1_R AGACTCAGGCTCGAAGGCAG 435 118722693
Exon2_F CTTGTGCCATGAAGGACTTCTC 118722013
Exon2_R CTGGAGAGCAGGAGGACACAG 429 118722441
Exon3_F CAGCTCCCTGGCATGGTAAC 118721847
Exon3_R CTCTGGAGGCGAGAAGATGG 360 118722206
Exon4_F CTTCTCCTGGCTCTGTGTCC 118721553
Exon4_R GCTGCAGAGATGGAGGTTAGAG 493 118722045
Exon5_F ACAGTCCAGTGAGTACTGGGG 118721219
Exon5_R CCCAGAGGTCTAGTCTCTCAATTTC 482 118721700
Exon6_F AGAGCTCCCTGGGACATCAG 118720655
Exon6_R GAACTCATCATGGGCACAGC 419 118721073
Exon7_F GGTGAGTGTGTTCCCACCTG 118720437
Exon7_R GACTGAGCAGGAAATGCTGAC 358 118720794
Exon8_F CTTTGGCCCAGAACTTGTTTC 118720107
Exon8_R CCGTCTGCTTGATCTCTGACC 327 118720433
Exon9_F TGAAACCAGGTAAATTAAAGGTCC 118719592
Exon9_R TTAGGGTGATGGTGAAGAGACC 447 118720038
Exon10_F CAGACCCTAACCCTGTGTCTTC 118718595
Exon10_R CACACCCTTACACCCTCCTG 465 118719059
Exon11_F AATGCCACGGAGAGTAGGTG 118718370
Exon11_R GTGAAGTGGTCCCAGAGTCAG 436 118718805
Exon12_F ATCCTCTTGCTTCCTCACAACC 118717661
Exon12_R AAATGCTGGTAGCAGGGCAG 374 118718034
Exon13_1_F AGGAGGTGGTAGAGGTCCTCAG 118717426
Exon13_1_R AAAAGAGGACGGGCAGGAAG 383 118717808
Exon13_2_F CACCCCACTAGGCAGTGTTC 118717141
Exon13_2_R ATCAAGGAAAAGGTCAGAAGGC 484 118717624
Exon13_3_F GGGGAAGAGAAGTCCTCAGC 118716989
Exon13_3_R CAGTGGCAGAGACCAAGGAC 353 118717341
Exon13_4_F GCATCTATTCATGTGGCAGGC 118716657
Exon13_4_R TACTCCGGACCCTCCAGTTG 466 118717122
Sixteen primer pairs were designed to amplify all 13 exons of the MFRP gene covering 50–150 bp of each intron-exon boundary.
“F” and “R” represent the forward and reverse primers, respectively. ‘bp’ – base pairs.
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disease.
In this study, mutation screening of the MFRP gene
revealed no sequence variants that would implicate this gene
in the development of moderate to high hyperopia, isolated
microphthalmia, isolated anophthalmia, or high-grade
myopia. In addition, we presented a family-based association
study of SNPs on the MFRP gene using a large family data
set. We did not identify any significant association results for
MFRP markers in moderate to high hyperopia and high-grade
myopia phenotypes. The family-based association tests
applied to this study are known to be robust against population
stratification and appropriate for multiplex families such as
those screened in this study [24,25].
Our results indicate that the MFRP gene may not be
primarily involved in ocular axial length regulation. It is
possible that MFRP performs a different role in disorders such
as isolated nanophthalmos and syndromic microphthalmia
(where mutations have been reported) both of which are
recognized as developmental disorders unlike hyperopia and
myopia. Although the microphthalmia/anophthalmia cohort
in this study could be considered developmental, we did not
observe any mutations in the MFRP gene in this cohort.
However, isolated microphthalmia and anophthalmia (unlike
syndromic) have been previously attributed to mutations in
the retinal homeobox gene (CHX10) [26,27], which is in
concurrence with the current findings, and future studies are
needed to confirm this line of thought.
No mutations were observed in exons 5 and 10, which
housed the previously reported MFRP gene mutations that
resulted in a mutant protein [3,4]. However, we observed
some coding synonymous (silent) single nucleotide
polymorphisms (SNPs) in exon 5 in six hyperopic and six
microphthalmic/anophthalmic subjects (approximately 60%)
in our sequencing data. While studies on the effect of silent
SNPs on protein structure are still emerging, there is a new
line of thought that silent SNPs can affect in vivo protein
folding and function by altering translation kinetics [28,29].
Further studies are needed to prove this; however, if this is the
case, there could be a potential role for the silent SNPs in the
MFRP gene reported in this study and future research should
take these findings into account.
Another possibility is that proteins that interact with the
MFRP gene could be involved in the regulation of ocular axial
length. It is reasonable to state that regulation of eye size is a
complex process and is likely to involve multiple genes. While
the previously reported MFRP mutations in isolated
nanophthalmos and syndromic microphthalmia may not
directly influence axial length programming, the resultant loss
of MFRP interaction involved in axial length regulation could
lead to reduced eye size in those phenotypes.
In conclusion, sequence variants of the MFRP gene do
not appear to be associated with either the less severe forms
of hyperopia, extreme forms of limited eye growth and
development, or high myopia. Our findings indicate that
MFRP is not primarily and directly involved in ocular axial
length regulation. Future studies revealing gene mutations in
TABLE 2. REFRACTIVE STATUS (SPHERE) FINDINGS OF HYPEROPIC AND MYOPIC SUBJECTS.
Moderate-high hyperopic subjects Refractive status OD (Diopters) Refractive status OS (Diopters)
1 +8.00 +9.25
2 +4.25 +4.00
3 +8.00 +9.25
4 +2.00 +2.00
5 +2.00 +2.25
6 +5.25 +3.75
7 +3.25 +2.25
8 +2.75 +3.00
9 +2.25 +3.25
10 +2.50 +2.50
11 +7.75 +3.25
High myopic subjects Refractive status OD (Diopters) Refractive status OS (Diopters)
12 −14.25 −14.5
13 −8.25 −7.875
14 −13.75 −13.625
15 −11.00 −9.875
16 −11.50 −11.375
17 −14.50 −13.50
18 −13.25 −14.00
Moderate to high hyperopic and high myopic patients were screened for MFRP sequence variants. Refractive error was measured
using streak retinoscopy to the closest 0.25 diopters (D).
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391disease phenotypes with altered ocular axial length and the
relationship of MFRP with these mutant genes will shed more
light on the precise role of MFRP.
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